SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Sprinklr appointed Jordi Ribas, Ph.D., a senior Microsoft executive with 26+ years of experience in Search & AI, to its Board of Directors as a Class II director effective August 17, 2026, following Board approval on August 10, 2026. Dr. Ribas was assigned to the Nominating and Corporate Governance Committee and Strategy Committee.
View raw filing on EDGAR →Evolution Metals & Technologies Corp. appointed General Thomas A. Bussiere (ret.) as an independent director and member of the Audit, Compensation, and Nominating and Corporate Governance Committees, effective August 13, 2026. General Bussiere brings 40 years of Air Force leadership experience, including command of Air Force Global Strike Command overseeing 33,000+ personnel and multi-billion-dollar programs.
View raw filing on EDGAR →The filing discloses the appointment of Lee McIntire as Chief Executive Officer effective August 11, 2026. While the disclosure also includes compensatory details (base salary of $750,000, annual bonus eligibility, $15,000 monthly housing allowance, and a $3,000,000 RSU grant), the principal action is the appointment of a named executive to a C-suite role. The appointment of a CEO is a material governance event affecting investor assessment of company leadership.
View raw filing on EDGAR →Scott Scheirman was appointed to Oportun's Board of Directors effective August 11, 2026, as a Class I director and Chair of the Audit & Risk Committee, bringing extensive executive and board experience from major financial services companies including prior CEO and CFO roles.
View raw filing on EDGAR →The filing announces three executive appointments: Phill Wood as CEO of the newly formed International Division (effective immediately), Rafael Carrasco as CEO of North America Division (joined 3 August 2026), and Matt Jochim as Group Chief Transformation Officer (effective 7 September 2026). These are material leadership changes affecting the Company's executive structure and strategic execution, particularly the appointment of a new Group Chief Transformation Officer to the Executive Leadership Team reporting directly to the CEO.
View raw filing on EDGAR →Kenneth J. Giacobbe was appointed to Carpenter Technology's Board of Directors as a Class III director, effective August 11, 2026. The appointment was accompanied by the concurrent departures of Howard Yu (resignation effective October 6, 2026) and Colleen Pritchett (not seeking re-election), with Giacobbe's extensive CFO experience at Howmet Aerospace making the board composition change material to investors.
View raw filing on EDGAR →Keith Demmings has been elected to Moody's Board of Directors, effective November 1, 2026. Demmings is the President and CEO of Assurant with nearly three decades of leadership experience and extensive global operating and insurance expertise. His director compensation arrangement includes a $120,000 annual retainer plus a $230,000 RSU award.
View raw filing on EDGAR →John Gerdin was appointed to American Fusion's Board of Directors as an Independent Director and Strategic Advisor, effective August 10–11, 2026. The appointment is structured through a Consulting Services Agreement with JRMS Consulting LLC and brings significant international finance and capital markets expertise to the company's leadership.
View raw filing on EDGAR →The filing discloses the appointment of Jeffrey F. DiModica to the Board of Directors effective August 10, 2026, and his appointment to the Investment Committee. While the section also mentions Jeffrey G. Dishner's resignation, the principal disclosed action centers on DiModica's appointment to the Board. DiModica's extensive background as President since 2014 and his prior directorship (2009–2014) make this a material governance event affecting board composition and oversight.
View raw filing on EDGAR →The exhibit announces the appointment of Peter Rawlins as Chief Financial Officer effective August 26, 2026, replacing interim CFO David Allen. While the exhibit also reports Q2 2026 financial results, the principal disclosed action is the executive appointment. The CFO role is material to a development-stage company executing a major refinery construction project, and Rawlins' extensive mining finance and capital markets experience is directly relevant to the company's funding and project execution priorities.
View raw filing on EDGAR →The filing discloses the appointment of Scott Colangelo to the Board of Directors effective August 11, 2026, and his concurrent appointment to the Audit Committee. The principal disclosed action is a person taking a role as director, which is the core event under Item 5.02(d). While the disclosure mentions standard director compensation arrangements, the focus is on the appointment itself rather than compensation terms, making exec_appointment the most salient classification.
View raw filing on EDGAR →Anthony Aliquo was appointed Chief Accounting Officer and principal accounting officer effective August 10, 2026, representing a material promotion from Vice President, Controller. While the filing also discloses that Fred Ahlholm ceased serving as principal accounting officer (a secondary change), the principal disclosed action centers on Aliquo's appointment to a named executive officer role. The appointment is accompanied by salary and bonus increases, confirming its significance.
View raw filing on EDGAR →The filing discloses two executive events: Nancy Hawthorne's retirement and resignation as Trustee and Chairperson, and Patrick Coyne's election to Chairperson. While both a departure and an appointment occur, the prose centers on the appointment of Coyne to the Chairperson position as the forward-looking action taken by the Board in response to Hawthorne's departure. The appointment of a new Chairperson is material to investors as it represents a change in board leadership.
View raw filing on EDGAR →Lawrence Burian was elected as a Class II Director to the Board of Directors of Cinemark Holdings, Inc., effective immediately, to fill a vacancy. The appointment includes standard non-employee director compensation of a $95,000 base retainer and an annual restricted stock grant of $175,000.
View raw filing on EDGAR →The filing discloses the appointment of Jonathan Peri, Ph.D., J.D. as an independent director to Citius Oncology's Board, effective August 10, 2026, expanding the Board to nine members. The Board determined Dr. Peri qualifies as independent under Nasdaq listing standards and will be compensated under the Company's director compensation program. This is a clear executive/director appointment event under Item 5.02(d).
View raw filing on EDGAR →The Board appointed Aaron Alt as an independent director effective August 14, 2026, and also appointed him to the Audit and Finance Committee. This is a clear executive appointment event. While the disclosure mentions that Mr. Alt will participate in standard non-employee director compensation arrangements, the principal disclosed action is the appointment itself, not a new or modified compensation arrangement, making exec_appointment the most salient classification.
View raw filing on EDGAR →The filing discloses both a departure (Riley McCormack's resignation from the Board) and an appointment (Paul Carreiro's election to the Board on the same date). While both events occurred, the appointment is the principal forward-looking action—Carreiro was elected to fill the vacancy and will serve until the next shareholder meeting. The appointment of a new director to the Board is material to investors' assessment of governance and leadership continuity.
View raw filing on EDGAR →John C. Reed, M.D., Ph.D., a highly accomplished pharmaceutical executive with significant experience at Johnson & Johnson, Sanofi, and Roche, was appointed to Madrigal's Board of Directors effective August 11, 2026, expanding the Board from eight to nine members. Dr. Reed will serve on the Science and Technology Committee and receive an annual cash retainer of $50,000, committee fee of $10,000, and an equity grant valued at $675,000.
View raw filing on EDGAR →The filing discloses the appointment of Keith C. Costello as Executive Vice President and Chief Operating Officer, effective August 17, 2026. While the disclosure also includes compensatory arrangements (base salary of $460,000, equity awards of 150,000 stock options and 150,000 RSUs, and severance provisions), the principal action is the appointment of a named executive officer to a senior operational role. The appointment of a COO is material to investors as it affects the company's leadership structure and operational oversight.
View raw filing on EDGAR →The disclosure centers on the appointment of Paul Cappuccio as Chief Legal Officer and Corporate Secretary, a named executive officer role. While Benjamin Lee's departure is mentioned, the principal action disclosed is the incoming appointment of Cappuccio to fill the CLO position. The CLO is a material executive role responsible for legal and governance functions, making this appointment material to investors.
View raw filing on EDGAR →Shane Harrison was appointed as Senior Vice President and Chief Financial Officer of Resideo, effective September 1, 2026, with compensation arrangements including a $550,000 base salary, $2,000,000 initial equity award, and $400,000 sign-on bonus.
View raw filing on EDGAR →Joseph A. Alkire is appointed to the role of President and Chief Financial Officer, a material promotion from his prior position as Executive Vice President, CFO and Global Head of Operations. While the disclosure also includes compensatory arrangements (base salary of $900,000, 120% bonus target, and $2.6M long-term incentive award), the principal disclosed action is the appointment to a new executive role. The appointment of a President is material to investors as it signals a significant change in the Company's leadership structure.
View raw filing on EDGAR →Effective August 7, 2026, Becky Fallon, Sean Michael Deegan, and Daniel M. McCabe were appointed as members of the board of directors in connection with the effectiveness of the Company's Registration Statement, with specified committee assignments and qualifications as independent directors and audit committee financial expert.
View raw filing on EDGAR →Pedro Abreu is transitioning from Vice President and Chief Strategy Officer to President, Power Systems, effective September 1, 2026, representing a promotion to a senior operational leadership role. Daniel Griffin is also appointed as President, Aftermarket Solutions. While this involves role changes within the executive team, the principal disclosed action centers on appointments to significant president-level positions overseeing major reportable segments, making exec_appointment the most salient classification.
View raw filing on EDGAR →Kelly Youngblood was appointed as Executive Vice President and Chief Financial Officer effective August 12, 2026, replacing Gregory A. Izenstark. The appointment includes a base salary of $680,000, a bonus target of 85%, a long-term incentive target of 225%, and a $2.03 million RSU grant.
View raw filing on EDGAR →Todd Kelsey was appointed to Littelfuse's Board of Directors effective August 6, 2026, and also appointed to the Compensation Committee. His appointment brings extensive global experience, technology and manufacturing expertise, and public company board experience to the company's governance and strategic direction.
View raw filing on EDGAR →ClearSign Technologies appointed Larry M. Saddler to its Board of Directors effective August 6, 2026, to fill a vacant directorship. Saddler is a retired ExxonMobil executive with 40+ years of industry experience in heat transfer and emissions reduction technology. The appointment includes annual cash compensation of $60,000 and stock option grants of $40,000, plus make-whole payments for covered RSUs.
View raw filing on EDGAR →The press release announces the appointment of J. Michael Rolland to Intermap's Board of Directors. This is a clear executive/governance appointment disclosing a person taking a board role. Rolland brings significant infrastructure financing experience and his appointment is explicitly framed as supporting the company's capital expansion strategy, making it material to investors assessing the company's leadership and strategic direction.
View raw filing on EDGAR →Aura Biosciences appointed Susan Abu-Absi as Chief Operating Officer effective August 10, 2026, with compensation terms including $520,000 base salary, 45% bonus target, and approximately 400,000 shares in equity awards (60% options, 40% RSUs). The company also appointed Erica Kratz as Chief Regulatory Officer and Julie Person as Chief People Officer.
View raw filing on EDGAR →ManpowerGroup appointed John B. Gibson, Jr., President and CEO of Paychex, to its Board of Directors effective September 1, 2026. The disclosure centers on the appointment of a director to the board and his committee assignment, with the board size increasing from ten to eleven directors. This is a clear executive appointment event under Item 5.02, material to investors as it affects board composition and governance.
View raw filing on EDGAR →Barry C. McCarthy, President and CEO of Deluxe Corporation, was appointed as a new director to Radian Group Inc.'s Board of Directors, increasing the Board size from eleven to twelve members. McCarthy brings nearly four decades of leadership experience in payments, financial services, and technology.
View raw filing on EDGAR →Elena Ridloff was appointed to the Board of Directors effective August 6, 2026, bringing 20+ years of biopharmaceutical leadership experience in finance, capital markets, and corporate development to strengthen the board's expertise as the company approaches pivotal Phase 3 readout. Dr. Daniel Vitt resigned from the board and his employment was terminated pursuant to a separation agreement.
View raw filing on EDGAR →PubMatic announced the appointment of Megan Ramm as Global Chief Revenue Officer, effective August 10, 2026. The disclosure centers on her taking a senior executive role leading global revenue strategy across all regions. While the filing also details her compensation package (base salary of $500,000, performance bonus target of $500,000, and equity awards totaling $5.75 million), the principal disclosed action is the appointment itself, not the compensation arrangement. This is material as it involves a key C-suite leadership position at the company.
View raw filing on EDGAR →The filing discloses the appointment of V. Ray Rivers to the Board of Directors effective August 10, 2026, and his concurrent appointment to the Audit Committee and Compensation Committee. The Item 5.02 disclosure emphasizes his extensive capital markets and financial services background, his independent director status under Nasdaq standards, and his compensation package ($25,000 annual retainer plus committee fees and equity grant). This is a clear director appointment that strengthens board expertise and is material to investors assessing governance quality.
View raw filing on EDGAR →The filing discloses the appointment of Vikas Choudhary as a director of Everspin Technologies, effective August 9, 2026. While the disclosure also includes compensatory arrangements (RSU award of $250,000 and annual cash retainer of $55,000), the principal action is the director appointment itself. The detailed biographical information and board service terms confirm this is a material executive appointment that would affect investor assessment of the company's governance and leadership.
View raw filing on EDGAR →Southwest Airlines appointed two new directors to its Board: Varun Krishna (CEO of Rocket Companies and interim CEO of Redfin) and Jason T. Liberty (Chair and CEO of Royal Caribbean Cruises Ltd.), effective immediately, increasing the Board size to thirteen members.
View raw filing on EDGAR →The filing discloses the appointment of Paul Hoelting to Werner Enterprises' Board of Directors to fill a Class I directorship vacancy, effective August 7, 2026. While the disclosure includes standard director compensation details (cash retainer, restricted stock award, committee fees), the principal action is the appointment itself. This is a material governance event affecting the composition of the board at a publicly traded transportation company with $3 billion in annual revenues.
View raw filing on EDGAR →The news release announces the appointment of Mark E. Smith as Chairman of the Board, effective immediately. While the release also discusses the 2026 site program at the Casino project, the principal disclosed action is a leadership change—a director since November 2025 being elevated to Chairman, succeeding Raymond Threlkeld. This is a material governance event affecting the registrant's board leadership and control structure.
View raw filing on EDGAR →The filing discloses the appointment of Scott Kotarba to the Board of Directors effective August 10, 2026, filling a vacancy created by Ian Wendler's retirement on July 31, 2026. While both a departure and an appointment occur, the principal disclosed action centers on the appointment of a new director. The filing details Mr. Kotarba's background, compensation ($12,000 annually plus 25 restricted shares per quarter), and his prior consulting relationship with the company. Board composition changes are material to investors assessing governance and oversight.
View raw filing on EDGAR →The 6-K announces three executive leadership changes effective August 10, 2026: appointment of Daniel Mamadou-Blanco to the board of directors and Investment Committee, appointment of Steve Zhang as Co-Chief Financial Officer, and promotion of Yi Bao to Chief Operating Officer. While the filing also discloses Bo Shen's departure from the board, the principal disclosed actions are the three appointments/promotions of new or elevated leadership roles. These are material governance events affecting the registrant's leadership structure and strategic direction.
View raw filing on EDGAR →Agomab Therapeutics announced the proposed appointments of Marino Garcia and Dr. Naimish Patel as non-executive members of the Board of Directors, to be submitted for shareholder approval at a Special General Meeting on September 11, 2026. Both candidates bring significant industry experience in biotechnology leadership and clinical development, directly relevant to the company's strategic direction.
View raw filing on EDGAR →The filing discloses the appointment of Qunxue Yin as Chief Executive Officer and Chairman of the Board effective immediately on August 8, 2026, following the resignation of Jialuan Ma on August 6, 2026. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new CEO and Chairman with detailed biographical information and qualifications. This is material as it represents a change in the Company's principal executive officer and board leadership.
View raw filing on EDGAR →The letter discloses multiple executive leadership transitions effective December 31, 2026 and August 3, 2026: Vivek Bantwal becomes sole Chief Executive Officer of the Goldman Sachs BDC complex; Justin Betzen becomes Co-President and Co-Chief Operating Officer alongside Tucker Greene; and Greg Watts and Steven Budig are elevated to co-heads of Americas Direct Lending. While David Miller's departure as Co-CEO is also mentioned, the primary focus and substance of the disclosure centers on the appointments and promotions of these executives into expanded roles, making exec_appointment the most salient classification.
View raw filing on EDGAR →Jeff D. Martinez was appointed as Senior Vice President, Utility Operations effective October 1, 2026, with a salary increase from $380,000 to $500,000, joining the Management Committee. James H. Jeffries IV was elected to the Board of Directors effective September 1, 2026. John S. McDill announced his retirement as Senior Vice President, Utility Operations in early 2027.
View raw filing on EDGAR →Natuzzi announces it has "signed a commitment letter with a candidate for the role of Chief Executive Officer." While the appointment is not yet finalized (it is a commitment letter with a candidate, not a completed appointment), the disclosure of a CEO succession process is material to investors assessing leadership continuity and strategic direction. The company emphasizes the candidate's "extensive international experience" and belief that his profile will support "ongoing restructuring process and long-term strategic development," indicating this is a significant governance event. The language suggests an imminent appointment rather than a speculative search.
View raw filing on EDGAR →The filing discloses the appointment of two new directors, David Benson and David Cush, to SAIC's Board effective August 20, 2026, with the Board size increasing from ten to twelve members. Both appointees bring substantial executive and board experience (Benson from Fannie Mae and Merrill Lynch; Cush from Virgin America and American Airlines), and will serve on key committees including the Audit Committee. This is a material governance event affecting board composition and oversight structure.
View raw filing on EDGAR →The filing discloses the appointment of Kashif Rashid as Chief Legal Officer and Corporate Secretary, effective August 10, 2026, following the Board's decision on August 6, 2026. While the section also includes Jeremy Hayden's departure as Chief Legal Officer, the principal disclosed action centers on the appointment of a new executive officer to a key leadership role. The appointment includes detailed employment terms (base salary of $450,000, 50% bonus target, severance provisions) and an RSU award of $1,400,000, making this a material executive appointment that would affect investor assessment of the company's leadership and governance.
View raw filing on EDGAR →The disclosure centers on the Board's appointment of Alan Musso as principal accounting officer effective August 7, 2026, following Greg Tourangeau's departure from that role. While both a departure and an appointment occur, the principal action disclosed is the appointment of Musso to the principal accounting officer position. The appointment of a principal accounting officer is a material governance event affecting the registrant's financial reporting oversight.
View raw filing on EDGAR →Annexon appointed Mark S. Blumenkranz, M.D., M.M.S. to its board of directors effective August 10, 2026, and assigned him to the Audit Committee and Science and Technology Committee. Dr. Blumenkranz brings significant expertise in retinal disease and biotechnology leadership to support the company's late-stage clinical programs.
View raw filing on EDGAR →The filing discloses the appointment of S. Wade Sheek as Chief Legal Officer and Corporate Secretary, effective August 17, 2026, replacing Nathaniel A. Vitan. While the section also mentions Vitan's transition to a senior advisor role, the principal disclosed action is the appointment of a named executive officer to a C-suite position. This is material as it affects the registrant's senior leadership and governance structure.
View raw filing on EDGAR →